InvestorsObserver
×
News Home

Analyst Rating: Will Kura Oncology Inc (KURA) Stock Lead the Market?

Monday, March 29, 2021 11:38 AM | InvestorsObserver Analysts

Mentioned in this article

Analyst Rating: Will Kura Oncology Inc (KURA) Stock Lead the Market?

InvestorsObserver is giving Kura Oncology Inc (KURA) an Analyst Rating Rank of 68, meaning KURA is ranked higher by analysts than 68% of stocks. The average price target for KURA is $41.428 and analyst’s rate the stock as a Strong Buy

Overall Score - 4.7
Wall Street analysts are rating KURA a Strong Buy today. Find out what this means to you and get the rest of the rankings on KURA!

Why are Analyst Ratings Important?

Though analyst projections should not be your only resource when determining your position on a stock, it can be a very useful tool. Analysts follow sectors/industries in-depth and tend to know how local and global conditions tend to affect demand and prices. Many analysts even participate in conference calls where they can get information to better make sense of the numbers.

InvestorsObserver averages the ratings provided by analysts and then ranks their score as a percent against the market. This allows you to compare stocks in a more comprehensive fashion than with the typical buy/sell/hold ranking.

What's Happening With Kura Oncology Inc Stock Today?

Kura Oncology Inc (KURA) stock is trading at $26.28 as of 11:35 AM on Monday, Mar 29, a drop of -$1.11, or -4.07% from the previous closing price of $27.39. The stock has traded between $26.05 and $27.42 so far today. Volume today is less active than usual. So far 317,774 shares have traded compared to average volume of 910,841 shares.

Click Here to get the full report on Kura Oncology Inc (KURA) Stock.

You May Also Like

Get the InvestorsObserver App

InvestorsObserver App
iOS App Android App